Cargando…
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors
BACKGROUND: Sodium and calcium polystyrene sulfonate (SPS/CPS) cation-exchange resins have had long-standing clinical use for hyperkalemia in patients with chronic kidney disease (CKD). However, uncertainty exists regarding the real-world usage of SPS/CPS for acute and chronic management of hyperkal...
Autores principales: | Ren, Hongru, Leon, Silvia J, Whitlock, Reid, Rigatto, Claudio, Komenda, Paul, Bohm, Clara, Collister, David, Tangri, Navdeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394712/ https://www.ncbi.nlm.nih.gov/pubmed/36003673 http://dx.doi.org/10.1093/ckj/sfac077 |
Ejemplares similares
-
Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort
por: Hougen, Ingrid, et al.
Publicado: (2021) -
The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis
por: Whitlock, Reid, et al.
Publicado: (2023) -
Magnitude of the Potential Screening Gap for Fabry Disease in
Manitoba: A Population-Based Retrospective Cohort Study
por: Whitlock, Reid H., et al.
Publicado: (2023) -
Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis
por: Nakamura, Teruko, et al.
Publicado: (2018) -
Metabolic Acidosis is Associated With Acute Kidney Injury in Patients With CKD
por: Zhu, Antonia, et al.
Publicado: (2022)